|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL 显示文摘 | Emery J G McDonnell P Burke M B | 1998 | J Biol Chem1998，273，14： | 2 |
| 2 | Adalimumab plus methotrexate results in less frequent and less severe radiographic progression than methotrexate alone at all levels of clinical response in early rheumatoid arthritis显示文摘 | Emery P Genovese MC Kavanangh AF | 2006 | Ann Rheum Dis2006，65，： | 1 |
| 3 | IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-turnout necrosis factor biologicals : results from a 24-week multicentre randomised placebo-controlled trial 显示文摘 | EMERY P KEYSTONE E TONY H P | 2008 | Ann Rheum Dis2008，67，11： | 1 |
| 4 | Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis 显示文摘 | EMERY P GABAY C KRAAN M | 2007 | Rheumatol Int2007，27，9： | 1 |
| 5 | IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals:results from a 24-week multicentre randomised placebo-controlled trial显示文摘 | Emery P Keystone E Tony HP | 2008 | Ann Rheum Dis2008，67，： | 1 |
| 6 | Infliximab:12 years of experience显示文摘 | Smolen JS Emery P | | 0，，1： | 1 |
| 7 | Rheumatoid arthritis pathophysiolo-gy: update on emerging cytokine and cytokine-associat-ed cell targets 显示文摘 | Furst DE Emery P | 2014 | Rheumatology (Oxford)2014，53，9： | 1 |
| 8 | Treatment of rheumatoid arthritis with the selective eostimulation modulator abatacept: twelve-month results of a phase Ⅱ b, double-blind, randomized, placebo-controlled trial显示文摘 | KREMER JM DOUGADOS M EMERY P | 2005 | Arthritis Rheum2005，52，8： | 1 |
| 9 | Comparison of methotrexate monotherapy with a combination of metho- trexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, doubleblind, parallel treatment trial 显示文摘 | Emery P Breedveld FC Hall S | 2008 | Lancet2008，372，9636： | 1 |
| 10 | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL 显示文摘 | Emery J G Mcdonnell P Burke M B | 1998 | J Biol chem1998，273，14： | 1 |
| 11 | Encouraging prospects for immuni2 sation against primary cytomegalovirus infection 显示文摘 | Griffiths P Mcleam A Emery V | 2001 | Vaccine2001，19，1112： | 1 |
| 12 | A comparison of the efficacy and safety of leflunomide and methotrexate for the treat- ment of rheumatoid arthritis 显示文摘 | EMERY P BREEDVELD F C LEMMEL E M | 2000 | Rheumatology2000，39，6： | 1 |
| 13 | Treatment of rheumatoid arthritis with the selective costimulation mod-ulator abatacept:twelve-month results of a phase i b, double-blind, randomized, placebo-control ed trial显示文摘 | Kremer JM Dougados M Emery P | | 0，，06： | 1 |
| 14 | Dose - effect relationships of nonsteroidal anti- inflammatory drugs: a literature review显示文摘 | Emery P Kong SX Ehrich EW | 2002 | Clin Ther2002，24，8： | 1 |
| 15 | Apoptosis alter traumatic human spinal cord injury显示文摘 | Emery E Aldana P Bunge MB | 1998 | J Neurosurg1998，89，6： | 1 |
| 16 | Apoptosis after traumatic human spinal cord injury显示文摘 | Emery E Aldana P Bunge MB | | 0，，06： | 1 |
| 17 | A compa- rison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis显示文摘 | EMERY P BREEDVELD FC LEMMEL EM | 2000 | Rheumatology (Oxford)2000，39，6： | 1 |
| 18 | Mesenchymal stem cell tissue engineering:techniques for isolation ,expansion and application 显示文摘 | Pountos I Corscadden D Emery P | 2007 | Injury2007，38，14： | 1 |
| 19 | Early rheumatoid arthritis:therapeutic strategies显示文摘 | Emery P | 1994 | Scand J Rheumatol Suppl1994，100，： | 1 |
| 20 | Matrix met alloproteinase 9, apoptosis, and vascular morphology in early arthritis显示文摘 | Fraser A Fearon U Reece R Emery P Veale D J | 2001 | Arthritis Rheum2001，44，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员